Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical Trial Ongoing for SEP-786, Oral Small...
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR...
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.5 | -2.22222222222 | 22.5 | 24.975 | 21.4501 | 154850 | 22.8816974 | CS |
4 | -1.5 | -6.3829787234 | 23.5 | 26.34 | 18.62 | 271841 | 22.37313803 | CS |
12 | -1.5 | -6.3829787234 | 23.5 | 26.34 | 18.62 | 271841 | 22.37313803 | CS |
26 | -1.5 | -6.3829787234 | 23.5 | 26.34 | 18.62 | 271841 | 22.37313803 | CS |
52 | -1.5 | -6.3829787234 | 23.5 | 26.34 | 18.62 | 271841 | 22.37313803 | CS |
156 | -1.5 | -6.3829787234 | 23.5 | 26.34 | 18.62 | 271841 | 22.37313803 | CS |
260 | -1.5 | -6.3829787234 | 23.5 | 26.34 | 18.62 | 271841 | 22.37313803 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관